PhosphoSens MTOR Protein Kinase Assays, Substrates & Recombinant Enzymes

Continuous, real-time assays that directly quantify MTOR catalytic activity — generating a full progress curve in every well for IC₅₀, mechanism, and selectivity studies.

  • Real-time kinetic or TRF endpoint formats
  • Optimized substrates and assay-ready kits
  • Compatible with physiological ATP and cofactors

Designed for: drug discovery, lead optimization, and mechanistic kinase research teams

 

PhosphoSens MTOR kinase assay kit — continuous real-time fluorescence

About MTOR

mTOR (mechanistic target of rapamycin) is a serine/threonine kinase and founding member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family. It assembles into two structurally and functionally distinct complexes: mTORC1, which is rapamycin-sensitive and regulated by nutrients, growth factors, and energy status via the PI3K/AKT and RAS/MAPK axes; and mTORC2, which phosphorylates AKT at Ser473 and regulates cytoskeletal organization. Key mTORC1 substrates include S6K1 (Thr389) and 4E-BP1 (Thr37/46), driving ribosome biogenesis and cap-dependent translation. mTOR integrates upstream signals from AMPK, TSC1/2, and Rheb GTPase to coordinate anabolic metabolism, autophagy, and cell growth. Hyperactivation of mTOR is documented in renal cell carcinoma, breast cancer, PTEN-null tumors, TSC1/TSC2 mutations, and metabolic disorders including type 2 diabetes. Its central role in oncogenesis and metabolic dysregulation makes mTOR a validated, high-priority drug target across multiple therapeutic areas.

Why PhosphoSens for MTOR?

mTOR presents significant assay challenges: its large molecular weight (~289 kDa), multi-subunit complex architecture, and low intrinsic catalytic rate make robust biochemical assay development difficult. Endpoint methods such as ADP-Glo and HTRF require fixed ATP concentrations that rarely reflect physiological levels (~1-5 mM), distorting Ki measurements and missing time-dependent inhibition kinetics critical for allosteric and covalent inhibitors. Radiometric assays offer sensitivity but lack real-time resolution and pose handling constraints. AssayQuant's PhosphoSens technology continuously monitors phosphorylation of validated mTOR peptide substrates (e.g., derived from S6K1 or 4E-BP1) via fluorescent chelation-enhanced sensors, generating full progress curves at physiological ATP. This enables accurate KM(ATP) determination, kinact/KI measurement for covalent probes, mechanistic mode-of-inhibition profiling, and early detection of compound interference — all in a homogeneous, no-wash, real-time format compatible with HTS workflows.

Key Pathways: PI3K/AKT/mTOR signaling AMPK energy sensing Autophagy regulation mTORC1-mediated translational control
Approved Inhibitors:
Everolimus (Afinitor, renal cell carcinoma/breast cancer/PNET Temsirolimus (Torisel, renal cell carcinoma Sirolimus (Rapamune, transplant rejection/LAM)

Talk to a Scientist

Have questions about MTOR assay design, selectivity panels, or covalent inhibitor characterization?

Ask Our Scientists →
How pricing works:
Select a kit or substrate below, then request a quote. Bundle discounts apply automatically.

Real-Time MTOR Activity Assays

Continuous, real-time fluorescent assays optimized for quantitative MTOR activity measurements, IC50 determination, and mechanistic studies.

Assay Format: Continuous kinetic fluorescence (real-time)

PhosphoSens-Kinetic assays directly quantify enzyme activity by continuously monitoring substrate phosphorylation or dephosphorylation in real time, generating a full progress curve in every well.

Learn more about PhosphoSens-Kinetic →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Kinetic Kinase Activity Kit - AQT0732

Ready-to-use assay kits containing substrate and all essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0732)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $425

Substrate

PhosphoSens Kinase Substrate AQT0732

Bulk PhosphoSens® substrate for assay development and high-throughput workflows.

Specifications

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

Ready to request pricing for MTOR?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

No PhosphoSens-Red format is currently available for MTOR.

Ready to request pricing for MTOR?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

No recombinant enzymes are currently available for MTOR.

🔬 150+ peer-reviewed citations · 🏛️ MIT spinout technology · ⚗️ PhosphoSens® validated by independent labs worldwide · Browse technical articles →

Frequently Asked Questions: MTOR Assays

What substrate does AssayQuant use for mTOR kinase assays?

AssayQuant employs PhosphoSens peptide substrates derived from validated physiological mTOR substrates such as S6K1 (Thr389 site) and 4E-BP1, engineered to incorporate the Sox-based fluorescent chelation sensor. These substrates enable continuous, real-time detection of phosphorylation without antibodies or secondary reagents, ensuring signal specificity and compatibility with complex compound libraries.

Can PhosphoSens mTOR assays be used to characterize allosteric and ATP-competitive inhibitors differently?

Yes. Because PhosphoSens generates full kinetic progress curves at variable ATP and substrate concentrations, researchers can determine mode of inhibition (competitive, non-competitive, mixed) directly from a single experiment. This is particularly valuable for mTOR, where rapalogs act allosterically at FRB/FKBP12 while ATP-competitive inhibitors (e.g., Torin1, INK128) show distinct kinetic signatures that endpoint assays cannot resolve.

How does running mTOR assays at physiological ATP improve drug discovery decisions?

Most endpoint assays use low ATP concentrations (10-100 uM) to maximize signal window, which artificially inflates potency for ATP-competitive inhibitors relative to their cellular activity. PhosphoSens assays can be run at near-physiological ATP (1-5 mM), yielding Ki values that better predict cellular and in vivo potency, reducing late-stage attrition caused by misleading biochemical IC50 data.

Data & Resources

Explore data and documents to support your kinase and phosphatase experiments. Download sample data, protocols and other resources to see how our assays perform and to help you get started in your own lab. All validation data generated using PhosphoSens® assays under recommended conditions.

Still have questions about our products?

Our scientists can help you choose the right assay format, substrate, and enzyme for your experiment.

Stay Informed

Want to hear the latest about our technology? Be among the first to learn about our latest products and services.